Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01223118 · ClinicalTrials.gov registry record · NA
Evaluation of the Impact of Vitrification on Oocytes
A NA study, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT01223118 is a NA study that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 120 participants.
The verdict
NCT01223118, a NA study, has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the rate of cryosurvival of mature oocytes following vitrification, and to then compare the reproductive potential of vitrified oocytes relative to those which have not been cryopreserved.
Interventions
- PROCEDURE Vitrification and PGD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2010-08 |
| Est. Completion | 2012-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01223118
The ClinicalTrials.gov registry entry for NCT01223118 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Reproductive Medicine Associates of New Jersey, which has 51 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitrification and PGD is the first listed.
NCT01223118 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01223118 about?
NCT01223118 is a clinical study titled "Evaluation of the Impact of Vitrification on Oocytes". The purpose of this study is to determine the rate of cryosurvival of mature oocytes following vitrification, and to then compare the reproductive potential of vitrified oocytes relative to those which have not been cryopreserved.
What is the current status of trial NCT01223118?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2010-08. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01223118?
The interventions under investigation include: Vitrification and PGD (PROCEDURE).
Who is sponsoring clinical trial NCT01223118?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.